ONC-782

N/A

Report date: 2022/07/19 16:45:18

Base Information

Drug NameONC-782
Drug Alias NameONC-782
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-Signal transducer CD24
TargetsSignal transducer CD24
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOncoc4 Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcroImmune GroupOncoc4 Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A